Stocks under $1 have a reputation to be speculative investments and the trade trends of these penny stocks are volatile.
Investors make a sizable number of investments in stocks under a dollar based on speculations and hope that the volatility of the stock trend shifts in their favor.
Penny stock investors burn a lot of their investment due to volatility. They also lose a lot of money due to poor decision-making behind the investment – now this is because penny stocks are often subjected to pump-and-dump plays by investors.
What Are Penny Stocks?
Penny stocks are low-priced, speculative securities traded outside major exchanges.
Typically valued at less than $5 per share, they represent small companies with high growth potential but also heightened volatility and risk.
Where To Buy Penny Stocks
Penny stocks can be purchased through various online brokerage platforms or over-the-counter markets.
It’s essential to research reputable brokers and understand the associated fees and risks before investing.
Why Penny Stocks Under $1?
Penny stocks under $1 are considered ultra-speculative due to their affordability and potential for substantial gains.
Investors are enticed by the opportunity to buy large quantities with limited capital, but this also magnifies the risk of significant losses.
The Risky Business of Penny Stocks
Investing in penny stocks carries substantial risks for their low liquidity, lack of financial history, and vulnerability to manipulation.
It makes them a breeding ground for fraud and pump-and-dump schemes.
Novice investors must exercise caution and conduct thorough due diligence before diving in.
List of Penny Stocks Under $1
Here are the 5 best stocks under 1 to buy now:
-
Sundial Growers Inc. (NASDAQ: SNDL)
The first stock in our list of top stocks under $1 to buy now is – Sundial Growers (SNDL).
It is known for producing, marketing, and selling cannabis that is specifically targeted for adult usage and is primarily inhalable products.
We chose Sundial because the growing trend in the cannabis market strongly indicates growth. Despite the pandemic shutdowns in 2020, SNDL shares have nearly doubled in value.
According to market research by The Brightfield Group, the Hemp CBD market will reach $16 billion by 2025.
The U.S. nutraceutical industry is expected to grow roughly by $100 billion this year which is good news for Sundial’s growth and expansion.
Furthermore, the US cannabis market has yet to reach its full potential because Federal regulations have yet to pass a bill to legalize marijuana in the USA.
When that happens, it will be open sesame for the cannabis industry to grow. The Canadian and European cannabis industry is expected to enter the US market if this bill passes.
SNDL already has a massive average volume of around 2.88 million for the past 90 days- which makes it super liquid.
Moreover, SNDL has expanded through acquisition to become the largest retail network in Canada.
Despite not having any pending acquisitions in the US market and having a relatively smaller market cap of $359 million the year-to-date performance of SNDL is -33%.
This creates an opportunity for investors by a huge margin. What makes SNDL a worthy cannabis stock is the comparative underperformance of the company in the market.
But the stock has a promising growth trend of the overall cannabis industry looming around.
-
Zomedica Corp (NYSE: ZOM)
The second stock in the list of best stocks under 1 is – Zomedica Corporation (ZOM).
It is an American-based veterinary health company that focuses on creating products for cats and dogs. ZOM is considered to be – an underdog penny stock.
In the first quarter of 2023, the company reported 45% rise in generating revenue of $5.5 million with a gross margin of 70%.
The ZOM stock’s performance in the past half-year is -26.72% but the year-to-date performance however is a double-digit growth of 26.69%.
ZOM has launched the VetGuardian zero-touch vital signs remote monitoring system through their direct salesforce and is expanding the launch through U.S. animal health distributors.
Additionally, they have chosen to pursue the acquisition of Structured Monitoring Products (SMP), the creators of the VetGuardian system, and the acquisition is currently in progress.
In May, ZOM also made a non-refundable deposit of $250,000 to exercise their acquisition option and will now conduct diligence to finalize a definitive acquisition agreement.
Moreover, ZOM has commenced manufacturing the TRUVIEWTM digital microscopy system at their Georgia center.
This system offers fully automated slide preparation, aiming to significantly improve veterinarian practice workflow and reduce the number of unreadable images resulting from suboptimal slide preparation.
The company plans to launch the TRUVIEWTM system during the current quarter.
We have placed ZOM stock in our list of best stocks under a dollar because although it had a muddy start into 2023.
But there are still very promising growth potentials ahead for the company and its market.
-
Inuvo Inc. (NYSE: INUV)
Next on our list is a Robinhood-based penny stock known as Inuvo Inc. (INUV).
It is an advertising agency that is relying on state-of-the-art AI technology to enhance its commercialization solutions.
Inuvo’s latest product has the potential to be revolutionary in the upcoming digital marketing trends.
Its patented AI-driven commerce solution is known as IntentKey. In fact, IntentKey is the key to the company’s success as a penny stock and beyond.
What is more interesting is that the company has partnered with Google and subsidiary Vertro which will allow it to reach the online audience for generating high-quality leads.
It will do so through the use of Google’s Web Search and AdSense For Search services. The company is showing promising metrics and growth in its fundamentals.
The Inuvo stock is now down by -4% in 2023 – and its year-over-year revenue declined to $11.8 million for the second first quarter of 2023 from $18.6 million a year ago.
But for fiscal 2022, INUV showed a strong growth of 265% and its gross margin grew to 73.1% this quarter from 53% in the same quarter last year.
The market cap of the company is $30 million and has a price-to-sale ratio of 0.44.
Software services and solutions like IntentKey are defining tools for the digital market era in which we are immersing.
This makes Inuvo a phenomenal among cheap stocks to buy now under $1 dollar.
These last two stocks are also worth watching over the next few weeks.
-
Oragenics Inc. (NYSE: OGEN)
Next on our list is Oragenics (OGEN), a US-based biotechnology company dedicated to fighting infectious diseases.
COVID-19 remains a concern for many people despite a large number of Americans having been immunized against it.
When it comes to escaping the pandemic, we have a long way to go based on the rise of the Delta variant.
The role of companies like Oragenics in this is crucial. As of right now, they are developing their own version of the COVID-19 vaccine.
Oragenics recently signed an exclusive global license deal with Inspirevax Inc. for BDX301, a novel intranasal mucosal adjuvant. This will be used in Oragenics’ lead intranasal COVID-19 vaccine, NT-CoV2-1.
They will jointly form a Development Committee, with representatives from both companies, to oversee the project. Oragenics will make milestone and royalty payments under this agreement.
There’s also an opportunity to extend the collaboration to develop more intranasal vaccines with Inspirevax’s adjuvants. Oragenics secured a grant from CQDM, a Canadian bioresearch consortium, for a variant-agnostic COVID-19 protein subunit vaccine project.
Collaborating with the National Research Council of Canada (NRC) and Inspirevax, the aim is to enhance their intranasal vaccine candidate NT-CoV2-1.
This collaboration enables OGEN to address the changing SARS-CoV-2 virus by developing broadly protective antigens, safeguarding against current and future variants.
The pan-coronavirus vaccine offers a universal solution, targeting mucosal immunity at the source, facilitating faster manufacturing, and requiring lower storage and transportation barriers.
This breakthrough could have a significant impact on combatting SARS-CoV-2 and future coronaviruses. The stock of this company comes with certain risks, as this vaccine is currently the only product it is working on.
Nevertheless, high-risk investors may find this a promising investment in the future.
-
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
New York-based Tonix Pharmaceuticals (TNXP) develops therapies for neurological and immunological disorders.
Their therapeutic areas range from post-traumatic stress disorder to fibromyalgia to major depressive disorder to agitation in Alzheimer’s patients. Tonix Pharmaceuticals offers a glimmer of hope to patients suffering from conditions with limited treatment options.
The potential arrival of their pipeline drugs in the market could be life-changing for these individuals. Moreover, the company is actively working on a multi-dose COVID-19 vaccine and products tailored to address long-term COVID symptoms.
Recently, Tonix made a significant stride in its evolution by acquiring two established products, Zembrace SymTouch and Tosymra, from Upsher-Smith Laboratories, LLC.
These drugs cater to adults experiencing acute migraines, both with or without aura. In 2022, these products amassed an impressive $23 million in sales.
This acquisition marks Tonix’s transition into a comprehensive biopharmaceutical enterprise and reinforces their expertise in central nervous system disorders.
Not only does it offer promising growth potential for the two existing products, but it also enhances Tonix’s commercial capabilities, preparing them for the potential launch of TNX-102 SL, their product candidate for fibromyalgia treatment.
Additionally, this acquisition aligns seamlessly with the development of TNX-1900, an intranasal potentiated oxytocin product candidate aimed at preventing headaches in chronic migraine sufferers.
TNXP demonstrated confidence in its future by repurchasing 16,700,269 shares of common stock through share repurchase programs.
The average price per share stood at $0.82, amounting to a gross aggregate cost of approximately $13.6 million.
This strategic move reflects Tonix Pharmaceuticals’ commitment to its growth trajectory and dedication to serving patients in need.
As the company continues its innovative efforts, there is a sense of optimism for those longing for better treatment options and potential breakthroughs in the field of medicine.
Tonix is often dubbed a “meme stock” on Reddit, given its massive following. To capitalize on its fluctuations, investors should vigilantly track updates. The key lies in astutely timing your investments for potential gains.
We have also compiled here a list of best potential stocks under $1:
No. | Ticker | Company | Industry | Market Cap | Performance (Year) | Price |
1 | CATX | Perspective Therapeutics, Inc. | Medical Devices | 172.09 | 97.27% | 0.63 |
2 | GAU | Galiano Gold Inc. | Gold | 146.9 | 66.20% | 0.65 |
3 | TRX | TRX Gold Corporation | Gold | 124.51 | 11.12% | 0.43 |
4 | XTNT | Xtant Medical Holdings, Inc. | Medical Devices | 116 | 76.35% | 0.88 |
5 | ASM | Avino Silver & Gold Mines Ltd. | Other Precious Metals & Mining | 84.2 | 24.26% | 0.69 |
6 | SCTL | Societal CDMO, Inc. | Drug Manufacturers – Specialty & Generic | 80.7 | 14.29% | 0.96 |
7 | LODE | Comstock Inc. | Real Estate Services | 70.3 | 14.97% | 0.69 |
8 | AGLE | Aeglea BioTherapeutics, Inc. | Biotechnology | 47.02 | 25.15% | 0.59 |
9 | HUBC | HUB Cyber Security (Israel) Ltd. | Software – Infrastructure | 41.04 | -97.02% | 0.42 |
10 | XPL | Solitario Resources Corp. | Other Industrial Metals & Mining | 37.6 | 10.78% | 0.56 |
11 | NLSP | NLS Pharmaceutics AG | Biotechnology | 28.49 | 45.02% | 0.86 |
12 | SATX | Satixfy Communications Ltd. | Communication Equipment | 27.9 | -96.45% | 0.35 |
13 | KIQ | Kelso Technologies Inc. | Railroads | 18.9 | 14.47% | 0.35 |
14 | CLRO | ClearOne, Inc. | Communication Equipment | 18.7 | 116.78% | 0.78 |
15 | GSUN | Golden Sun Education Group Limited | Education & Training Services | 15.79 | -96.93% | 0.86 |
16 | CBIO | Catalyst Biosciences, Inc. | Biotechnology | 15.5 | 49.48% | 0.43 |
17 | NRBO | NeuroBo Pharmaceuticals, Inc. | Biotechnology | 13.3 | -96.87% | 0.51 |
18 | IONM | Assure Holdings Corp. | Medical Care Facilities | 10.42 | -96.77% | 0.82 |
19 | CYTO | Altamira Therapeutics Ltd. | Biotechnology | 3.1 | -96.39% | 0.34 |
20 | HOOK | HOOKIPA Pharma Inc. | Biotechnology | 70.4 | -45.28% | 0.87 |
Penny Stock Strategies
Penny stocks, low-priced equities typically traded outside major exchanges, have garnered both fascination and skepticism in the financial world.
While these stocks offer the allure of astronomical gains, they come with substantial risks.
As such, investors should approach them with caution and adopt specific strategies to optimize their chances of success.
-
Diligent Research and Due Diligence
Thorough research is paramount when dealing with penny stocks. Investigate the company’s fundamentals, financials, and management team.
Scrutinize market trends and industry outlooks to make informed decisions.
By performing due diligence, you can identify viable opportunities from possible scams in order to safeguard your investment.
-
Risk Management and Diversification
Due to their volatile nature, penny stocks can be highly unpredictable. Employ risk management techniques like stop-loss orders to protect your capital from significant losses.
Diversifying your portfolio across various industries can mitigate risk and balance potential rewards.
-
Technical Analysis for Entry and Exit Points
Utilize technical analysis to identify suitable entry and exit points. Analyzing price charts and patterns can assist in timing trades, optimizing gains, and minimizing losses.
-
Avoiding Emotional Trading
Stay rational and avoid emotional trading. Penny stocks’ rapid price fluctuations may trigger impulsive decisions, leading to regrettable outcomes.
Adopt a disciplined approach and stick to a well-defined strategy.
How To Trade Penny Stocks
While Penny stocks can be enticing due to their low entry costs and potential for rapid gains, they also carry significant risks.
To trade penny stocks effectively, conduct thorough research on companies, focusing on financials and potential catalysts.
Develop a disciplined strategy and stick to it, avoiding impulsive decisions. Diversify your portfolio to mitigate risks and set clear entry and exit points.
Stay updated with market trends and news to make informed choices.
Penny Stock Rules
Before delving into penny stock trading, it is essential to understand the rules that govern these volatile securities. Some key rules include:
-
Research Extensively
Penny stocks often lack sufficient information, making thorough research critical. Analyze company fundamentals, financials, news, and market trends before investing.
-
Limit Orders Are Crucial
Due to high volatility, place limit orders instead of market orders to control the price at which you buy or sell penny stocks.
-
Diversify Your Portfolio
Avoid putting all your funds into a single penny stock. Diversification can help mitigate risk.
-
Be Cautious Of Pump And Dump Schemes
Beware of fraudulent practices where scammers artificially inflate stock prices before selling their shares.
-
Understand Market Trends
Keep an eye on overall market trends and industry performance to make informed decisions.
How To Find Stocks Under $1
Finding penny stocks with potential requires a systematic approach. Here are some methods to identify these stocks:
-
Screening Tools
Utilize stock screening tools and platforms that allow you to filter stocks based on specific criteria, including price, market capitalization, and volume.
-
Stock News and Websites
Follow financial news outlets and websites that focus on penny stocks. They often highlight companies with promising prospects.
-
Social Media and Forums
While it’s essential to be cautious, social media platforms and online forums may offer insights into trending penny stocks.
-
Company Filings
Access the SEC’s EDGAR database to examine a company’s financial reports and disclosures.
Pros And Cons of Stocks Under $1
Trading penny stocks comes with advantages and disadvantages. Understanding these can help you make informed decisions:
Pros |
|
Low Entry Cost | Penny stocks allow investors with limited capital to enter the stock market. |
High Growth Potential | Some penny stocks experience exponential growth, providing significant returns. |
Volatility Opportunities | Rapid price movements present opportunities for short-term traders. |
Cons |
|
High Risk | Penny stocks are highly volatile and can lead to substantial losses. |
Lack of Information | Many penny stock companies have limited publicly available information, making due diligence challenging. |
Liquidity Concerns | Low trading volumes can result in difficulties when buying or selling large quantities. |
Top Platforms to Trade Best Stocks Under $1
Selecting the right trading platform is crucial for successful penny stock trading. Some popular platforms that offer access to best stocks under 1 include:
-
Robinhood
Known for its user-friendly interface and commission-free trading, Robinhood is favored by many beginner traders.
-
E-Trade
With a wide range of investment options and research tools, E-Trade caters to both beginners and experienced traders.
-
TD Ameritrade
This platform offers a variety of educational resources and advanced trading tools.
-
Fidelity
Fidelity is a well-established platform that provides access to penny stocks alongside other investment products.
Should You Invest in Penny Stocks?
Deciding whether to invest in penny stocks depends on your risk tolerance, investment goals, and trading experience. Consider the following factors before making a decision:
- Risk Tolerance: If you can withstand significant volatility and potential losses, penny stocks may be an option.
- Experience: Penny stocks are not recommended for novice investors due to their complexity.
- Diversification: Never allocate your entire portfolio to penny stocks. Maintain a diversified investment approach.
- Long-Term Vs. Short-Term: Determine whether you are a long-term investor or a short-term trader.
List of the Best Stocks Under $10
Although we have comprehensively discussed various cheap stocks to buy now under $1 dollar to consider investment in, listed below are the best performing stocks under $10 that you can get in the market:
No. | Ticker | Company | Industry | Market Cap | Perf (Year) | Price |
1 | ARDX | Ardelyx, Inc. | Biotechnology | 733.48 | 404.31% | 3.51 |
2 | AAOI | Applied Optoelectronics, Inc. | Communication Equipment | 237.06 | 325.27% | 7.91 |
3 | APLD | Applied Digital Corporation | Capital Markets | 741.89 | 210.04% | 7.72 |
4 | RIG | Transocean Ltd. | Oil & Gas Drilling | 6277.18 | 179.31% | 8.1 |
5 | WULF | TeraWulf Inc. | Capital Markets | 729.42 | 112.21% | 3.65 |
6 | BTBT | Bit Digital, Inc. | Capital Markets | 325.2 | 106.25% | 3.96 |
7 | CX | CEMEX, S.A.B. de C.V. | Building Materials | 11317 | 89.51% | 7.41 |
8 | RKLB | Rocket Lab USA, Inc. | Aerospace & Defense | 3738.3 | 71.62% | 7.5 |
9 | NU | Nu Holdings Ltd. | Banks – Diversified | 36299.4 | 71.43% | 7.92 |
10 | HUT | Hut 8 Mining Corp. | Capital Markets | 1052.7 | 69.63% | 3.63 |
Features to Look for in Best Stocks Under $10
Whether you are looking for hot stocks to buy under $10 or are simply interested in stocks under one dollar, it is important to focus your sights on a number of features regarding the particular stocks.
Each of the stocks mentioned in this article, including the stocks under $1, hold these features within them:
-
Growth Potential
Look for companies with strong growth potential that are likely to increase their revenue and earnings over time.
This can be indicated by positive earnings growth, expanding margins, and increasing market share.
-
Attractive Valuation
Consider stocks that are reasonably priced relative to their earnings, cash flow, and other metrics.
Avoid companies that appear to be overvalued or have a high price-to-earnings ratio. This is true for stocks under $1.
-
Competitive Strengths
Select stocks of companies with a competitive advantage, such as a unique product or service, a strong brand, or proprietary technology.
These companies are better positioned to maintain their market position and continue to grow over time.
-
Financial Stability
Look for companies with solid financials, including a healthy balance sheet, low debt levels, and positive cash flow.
Companies with strong financials are better able to weather economic downturns and other challenges, even for stocks under $1.
Conclusion
Exploring the world of best stocks under $1 can be a rewarding venture for investors seeking potential growth opportunities.
These low-priced stocks often present the chance to enter burgeoning markets or emerging companies with significant upside potential.
However, it is crucial to approach such investments with caution and thorough research.
Due to their inherent volatility and speculative nature, a diversified portfolio strategy is recommended to mitigate risks.
Investors should remain focused on long-term growth prospects, keeping an eye on the fundamentals of the companies in question.
While these stocks may carry higher risk, their potential for substantial returns can be enticing for those willing to embrace a calculated approach to their investment journey.
FAQs
How Can I Invest $1000 In Penny Stocks?
Investing $1000 in penny stocks can be a high-risk, speculative endeavor.
Conduct thorough research on the companies you’re interested in, considering their financial health and growth potential.
Diversify your portfolio to reduce risk, and set stop-loss orders to protect your investment. Stay disciplined and avoid impulsive decisions. Seek advice from financial experts if uncertain.
Is Investing In Stocks Under $1 Profitable?
Investing in stocks under $1 can be alluring due to their affordability, but it carries significant risks.
While some may see explosive gains, many low-priced stocks are highly volatile and susceptible to manipulation.
Prudent investors should exercise caution, conduct thorough research, and diversify their portfolios to mitigate potential losses.
Why Do Most Penny Stocks Fail?
Most penny stocks fail due to their inherent risks and speculative nature. Often associated with small, volatile companies, they lack financial stability and regulatory scrutiny.
Their low prices attract inexperienced investors seeking quick gains, leading to inflated demand and subsequent crashes.
Limited liquidity, poor fundamentals, and susceptibility to manipulation contribute to the high failure rate.
Do Penny Stocks Ever Go Big?
Penny stocks, though highly speculative, hold the potential to skyrocket. Unpredictable market forces can propel them to exponential growth, turning small investments into significant returns.
However, caution is advised due to their inherent volatility, susceptibility to scams, and lack of liquidity. Diligent research and risk management are crucial for success.